Coffee Enemas

Coffee Enemas — scientific infographic poster

Coffee enemas are one of the most disputed practices in the detoxification field. They have been a core element of the Gerson therapy since the 1940s, and New York physician Nicholas Gonzalez used them within an enzyme-based regimen for pancreatic cancer that a National Cancer Institute–sponsored study at Columbia University later evaluated. The mechanism proponents describe rests on coffee compounds reaching the liver and raising detoxification-enzyme activity and bile flow. The enzyme finding traces to mouse studies in which green coffee beans were fed in the diet, and no study found has tested coffee enemas for that effect. A 2020 systematic review found no study reporting the effectiveness of coffee enemas, while case reports describe colitis, rectal burns, septicemia and deaths from electrolyte depletion. This page covers the history, the proposed mechanism, the clinical evidence, the reported harms, and how proponents describe the practice.


Table of Contents

  1. History — Merck Manual to Gerson to Gonzalez
  2. Proposed Biochemical Mechanism
  3. The Gerson Therapy Context
  4. The Gonzalez Pancreatic Cancer Trial
  5. Available Clinical Evidence (and Gaps)
  6. Preparation as Proponents Describe It
  7. Administration as Proponents Describe It
  8. Frequency in Published Descriptions
  9. Adverse Events and Who the Research Raises Concerns For
  10. Key Research Papers
  11. Connections
  12. Featured Videos

History — Merck Manual to Gerson to Gonzalez

Coffee enemas have been in use for at least 150 years, according to a 2021 narrative review by a practitioner who uses them (Isaacs 2021). Proponents point out that coffee enemas appeared in earlier editions of the Merck Manual, a standard physicians' reference; the editions and indications cited vary between accounts, and the practice later disappeared from conventional references.

Max Gerson, a German-American physician who treated cancer patients in the 1940s and 1950s, made coffee enemas a structural element of his treatment. In his 1958 book A Cancer Therapy: Results of Fifty Cases, Gerson argued that the breakdown of tumors under his plant-based dietary regimen produced a heavy toxic load for the liver, and that coffee enemas sped the excretion of those breakdown products through the bile. A 2010 summary in Oncology describes the Gerson view that coffee enemas dilate the bile ducts and promote excretion of toxic breakdown products, and states that none of these theories has been substantiated by scientific research (Cassileth 2010).

Nicholas Gonzalez, a New York physician, treated advanced pancreatic cancer in the 1990s with large doses of oral pancreatic enzymes, nutritional supplements, an organic diet and “detoxification” procedures that included coffee enemas. His 1999 pilot study of 11 patients reported survival above national figures (Gonzalez & Isaacs 1999). A later National Cancer Institute–sponsored study at Columbia University compared the regimen with gemcitabine-based chemotherapy and found that patients who chose chemotherapy lived about three times as long (Chabot 2010); Gonzalez disputed how that study was conducted.

Back to Table of Contents

Proposed Biochemical Mechanism

The biochemical rationale offered by Gerson, Gonzalez and later proponents has several parts. What each part rests on:

The enzyme findings come from animals fed coffee, and the two human studies of the enema route found lower caffeine exposure than oral coffee and no rise in serum glutathione. Whether the practice produces the effects its proponents describe has not been shown.

Back to Table of Contents

The Gerson Therapy Context

In the Gerson therapy, coffee enemas are one part of a larger program. Published descriptions of the therapy list:

Because the elements are used together, no study has isolated the effect of the coffee enemas themselves. A 2010 summary states that case reviews by the National Cancer Institute and the New York County Medical Society found no evidence of usefulness for the Gerson diet, despite proponents' claims of recovery rates as high as 70% to 90% (Cassileth 2010).

A 1995 retrospective review of 153 melanoma patients treated at a Gerson-style hospital in Tijuana reported 5-year survival rates above those published elsewhere for each stage (Hildenbrand 1995). Coffee enemas were used “as needed for pain and appetite” in that cohort. The comparison was with survival figures from other published series, not a randomized or concurrent control group.

Back to Table of Contents

The Gonzalez Pancreatic Cancer Trial

The Gonzalez regimen for pancreatic cancer centered on large doses of orally taken pancreatic enzymes, with nutritional supplements, an organic diet and “detoxification” procedures including coffee enemas. Gonzalez held that the enzymes were the main anti-tumor element and that coffee enemas helped clear the breakdown products of tumor cells.

The 1999 pilot study (Gonzalez & Isaacs, Nutr Cancer 1999;33(2):117-24) followed 11 patients with inoperable stage II–IV pancreatic adenocarcinoma treated in the authors' private practice. Nine (81%) survived one year, five (45%) survived two years and four survived three years. The authors compared these figures with the 25% one-year and 10% two-year survival reported for all stages of the disease in the 1995 National Cancer Data Base. The study had a single treatment arm, no control group and no blinding.

The follow-up study (Chabot JA et al., J Clin Oncol 2010) began in 1998 as a National Cancer Institute–sponsored randomized phase III trial. Because most eligible patients refused random assignment, it was changed in 2001 to a controlled observational study in which patients chose their treatment. Of 55 patients with inoperable pancreatic cancer, 23 chose gemcitabine-based chemotherapy and 32 chose the enzyme regimen. Median survival was 14 months with chemotherapy and 4.3 months with the enzyme regimen, the adjusted mortality hazard ratio for the enzyme group was 6.96, one-year survival was 56% versus 16%, and quality-of-life ratings were better in the chemotherapy group. Gonzalez disputed the conduct and conclusions of the study.

Back to Table of Contents

Available Clinical Evidence (and Gaps)

A summary of the clinical evidence for coffee enemas:

A 2020 systematic review that searched Western, Korean, Chinese and Japanese databases found no study reporting the effectiveness of coffee enemas; the nine studies it found were case reports of adverse events, and its authors did not recommend self-administered coffee enemas as a self-care practice (Son 2020). Proponents attribute the lack of trials to the absence of a commercial sponsor; the one National Cancer Institute–sponsored evaluation tested the Gonzalez regimen as a whole, not coffee enemas alone.

Back to Table of Contents

Preparation as Proponents Describe It

The Gerson Institute and practitioners in the Gerson and Gonzalez traditions publish their own preparation instructions. In outline, these describe ground coffee boiled and simmered in water, strained to remove the grounds, and cooled to body temperature before use, with about one quart (roughly one liter) per session; brewing times, coffee amounts and roasts differ between sources. Proponents specify caffeinated coffee because they regard caffeine as part of the mechanism, although the oral-coffee gallbladder study found that decaffeinated coffee contracted the gallbladder too (Douglas 1990).

For comparison, the 2013 pharmacokinetic study gave volunteers 500 mL of coffee solution retained for 10 minutes (Teekachunhatean 2013).

Temperature is the preparation detail that appears in the harm literature: several case reports describe rectal burns from coffee that was still hot, one of them followed by a stricture and rectal perforation (Sashiyama 2008; Jones 2010; Kim 2012).

Back to Table of Contents

Administration as Proponents Describe It

Gerson-tradition descriptions have the person lie on the right side with the knees drawn up while the coffee flows in by gravity from an enema bag, retain it for a period, and then evacuate. Proponents explain the right-side position as aiding exposure of the liver through the portal circulation; that rationale has not been tested. The case reports of rectal burns, colitis and perforation all involved self-administration (Son 2020).

Back to Table of Contents

Frequency in Published Descriptions

Frequency varies by source and indication. Gerson's own cancer regimen called for several coffee enemas a day; in the 1995 melanoma cohort they were used as needed for pain and appetite (Hildenbrand 1995). No study has compared frequencies.

The deaths reported in the medical literature involved very frequent self-administration: the two patients described by Eisele and Reay, as summarized in the 2020 systematic review, used coffee enemas at high frequency and had low sodium and chloride levels at autopsy (Eisele & Reay 1980; Son 2020).

Back to Table of Contents

Adverse Events and Who the Research Raises Concerns For

Adverse events reported in the medical literature:

The two deaths and the septicemia case occurred in people who were already seriously ill, including people with advanced cancer and liver involvement, and who used coffee enemas many times a day (Son 2020). No study has defined who can use coffee enemas safely or at what frequency.

Coffee enemas remain a contested practice. Decisions about any medical or alternative treatment belong with a clinician.

Back to Table of Contents

Key Research Papers

  1. Gonzalez NJ, Isaacs LL. Evaluation of pancreatic proteolytic enzyme treatment of adenocarcinoma of the pancreas, with nutrition and detoxification support. Nutr Cancer. 1999;33(2):117-24 (pilot study) — PubMed PMID: 10368805
  2. Chabot JA, Tsai WY, Fine RL, Chen C, Kumah CK, Antman KA, Grann VR. Pancreatic proteolytic enzyme therapy compared with gemcitabine-based chemotherapy for the treatment of pancreatic cancer. J Clin Oncol. 2010;28(12):2058-63 — PubMed PMID: 19687327
  3. Reed A, James N, Sikora K. Juices, coffee enemas, and cancer. Lancet. 1990;336(8716):677-8 — PubMed PMID: 1975864
  4. Eisele JW, Reay DT. Deaths related to coffee enemas. JAMA. 1980;244(14):1608-9 — PubMed PMID: 7420666
  5. Lee CJ, Song SK, Jeon JH, Sung MK, Cheung DY, Kim JI, Kim JK, Lee YS. [Coffee enema induced acute colitis] (in Korean; case report). Korean J Gastroenterol. 2008;52(4):251-4 — PubMed PMID: 19077527
  6. Teekachunhatean S, Tosri N, Rojanasthien N, Srichairatanakool S, Sangdee C. Pharmacokinetics of caffeine following a single administration of coffee enema versus oral coffee consumption in healthy male subjects. ISRN Pharmacol. 2013;2013:147238 — PubMed PMID: 23533801
  7. Lam LK, Sparnins VL, Wattenberg LW. Isolation and identification of kahweol palmitate and cafestol palmitate as active constituents of green coffee beans that enhance glutathione S-transferase activity in the mouse. Cancer Res. 1982;42(4):1193-8 — PubMed PMID: 7059995
  8. Cassileth B. Gerson regimen. Oncology (Williston Park). 2010;24(2):201 — PubMed PMID: 20361473
  9. Hildenbrand GL, Hildenbrand LC, Bradford K, Cavin SW. Five-year survival rates of melanoma patients treated by diet therapy after the manner of Gerson: a retrospective review. Altern Ther Health Med. 1995;1(4):29-37 — PubMed PMID: 9359807
  10. Higdon JV & Frei B, Coffee and health: a review of recent human research (kahweol / cafestol section) — PubMed PMID: 16507475
  11. Cavin C et al., Cafestol and kahweol, two coffee specific diterpenes with anticarcinogenic activity. — PubMed PMID: 12067578
  12. Green S. A critique of the rationale for cancer treatment with coffee enemas and diet. JAMA. 1992;268(22):3224-7 — PubMed PMID: 1433763
  13. Lam LK, Sparnins VL, Wattenberg LW. Effects of derivatives of kahweol and cafestol on the activity of glutathione S-transferase in mice. J Med Chem. 1987;30(8):1399-403 — PubMed PMID: 3612687
  14. Teekachunhatean S, Tosri N, Sangdee C, Wongpoomchai R, Ruangyuttikarn W, Puaninta C, Srichairatanakool S. Antioxidant effects after coffee enema or oral coffee consumption in healthy Thai male volunteers. Hum Exp Toxicol. 2012;31(7):643-51 — PubMed PMID: 22249393
  15. Douglas BR, Jansen JB, Tham RT, Lamers CB. Coffee stimulation of cholecystokinin release and gallbladder contraction in humans. Am J Clin Nutr. 1990;52(3):553-6 — PubMed PMID: 2393014
  16. Son H, Song HJ, Seo HJ, Lee H, Choi SM, Lee S. The safety and effectiveness of self-administered coffee enema: a systematic review of case reports. Medicine (Baltimore). 2020;99(36):e21998 — PubMed PMID: 32899046
  17. Margolin KA, Green MR. Polymicrobial enteric septicemia from coffee enemas. West J Med. 1984;140(3):460 — PubMed PMID: 6710988
  18. Keum B, Jeen YT, Park SC, Seo YS, Kim YS, Chun HJ, Um SH, Kim CD, Ryu HS. Proctocolitis caused by coffee enemas. Am J Gastroenterol. 2010;105(1):229-30 — PubMed PMID: 20054322
  19. Lee AH, Kabashneh S, Tsouvalas CP, Rahim U, Khan MY, Anees M, Levine D. Proctocolitis from coffee enema. ACG Case Rep J. 2020;7(1):e00292 — PubMed PMID: 32309489
  20. Sashiyama H, Hamahata Y, Matsuo K, Akagi K, Tsutsumi O, Nakajima Y, Takaishi Y, Takase Y, Arai T, Hoshino T, Tazawa A, Fu KI, Tsujinaka Y. Rectal burn caused by hot-water coffee enema. Gastrointest Endosc. 2008;68(5):1008 — PubMed PMID: 18657805
  21. Jones LE, Norris WE. Rectal burn induced by hot coffee enema. Endoscopy. 2010;42 Suppl 2:E26 — PubMed PMID: 20073005
  22. Kim S, Cha JM, Lee CH, Shin HP, Park JJ, Joo KR, Lee JI, Jeun JW, Lim K, Lim JU, Choi JH. Rectal perforation due to benign stricture caused by rectal burns associated with hot coffee enemas. Endoscopy. 2012;44 Suppl 2 UCTN:E32-3 — PubMed PMID: 22396264
  23. Isaacs LL. Coffee enemas: a narrative review. Altern Ther Health Med. 2021;27(3):46-49 — PubMed PMID: 33711817

PubMed Topic Searches

  1. PubMed: Coffee enema
  2. PubMed: Gerson therapy

Back to Table of Contents

Connections

Back to Table of Contents